Lumos Pharma (LUMO) and Double Point Ventures announced the completion of the previously announced tender offer for Lumos Pharma’s shares at a purchase price of $4.25 per share in cash at ...
GlobalData on MSN2mon
DPV set to acquire Lumos Pharma for $38mDouble Point Ventures (DPV) has entered a definitive merger agreement to acquire all outstanding shares of Lumos Pharma for ...
AUSTIN, Texas and GREENWICH, Conn., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO) (“Lumos Pharma” or the “Company”), a clinical stage biopharmaceutical company focused ...
Lumos Pharma, Inc. and Double Point Ventures LLC announced the completion of a tender offer for Lumos Pharma's shares, with a purchase price of $4.25 per share in cash and one contingent value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback